Patient characteristics
| Derivation | Validation | p-value | |
|---|---|---|---|
| Total | 214 | 213 | |
| Male | 107 | 104 | 0.8 |
| Age | 60 ± 15 | 60 ± 15 | 0.6 |
| BSA (m2) | 1.87 ± 0.23 | 1.87 ± 0.23 | 0.8 |
| Healthy Volunteer | 33 | 33 | |
| Aortic Stenosis | 62 | 61 | |
| Cardiac Amyloidosis | 37 | 37 | |
| Hypertrophic Cardiomyopathy | 34 | 34 | |
| Anthracycline | 48 | 48 | |
| Cardiac | |||
| EDVi (ml/m2) | 71 ± 21 | 70 ± 20 | 0.9 |
| ESVi (ml/m2) | 25 ± 14 | 24 ± 13 | 0.5 |
| LV mass index (g/m2) | 90 ± 35 | 92 ± 35 | 0.5 |
| SVi (ml/m2) | 47 ± 12 | 47 ± 13 | 0.7 |
| LVEF (%) | 66 ± 12 | 67 ± 12 | 0.7 |
| LAAi (cm2/m2) | 14 ± 3 | 14 ± 5 | 0.5 |
| RAAi (cm2/m2) | 12 ± 4 | 12 ± 4 | 0.9 |
| Clinical | |||
| Hematocrit | 0.40 ± 0.04 | 0.40 ± 0.04 | 0.4 |
| Createnine | 79 ± 24 | 78 ± 21 | 0.9 |
| eGFR | 80 ± 23 | 78 ± 22 | 0.4 |
| Systolic BP (mmHg) | 110 ± 44 | 108 ± 49 | 0.7 |
| Diastolic BP (mmHg) | 65 ± 28 | 62 ± 31 | 0.5 |
| T1 Mapping | |||
| SHMOLLI ECV (%) | 33 ± 10 | 33 ± 11 | 0.9 |
BSA, body surface area; BP, blood pressure; ECV, extracellular volume fraction; EDVi, indexed end-diastolic volume; ESVi, indexed end-systolic volume; eGFR, estimated glomerular filtration rate; LAAi, indexed left atrial area; LVEF, left ventricular ejection fraction; RAAi, indexed right atrial area; ShMOLLI, Shortened Modified Look-Locker Inversion recovery; SVi, indexed stroke volume